PATENT CLAIM ANALYSIS

Application Number: 15952504
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "167000"]

Abstract:
In an embodiment, compositions comprising monoacylglycerols (MAG), such as sn-1 MAG, are administered with a lipase inhibitor, such as tetrahydrolipstatin, and/or with a diet low in fat and/or calories. In another embodiment, compositions comprising MAG, such as sn-1 MAG, are administered concurrently with a lipase inhibitor, such as tetrahydrolipstatin, and/or with fat-soluble nutrients. The compositions and the methods of using the compositions enhance absorption of fatty acids and fat-soluble nutrients such as fat-soluble vitamins and carotenoids to address nutritional deficiencies due to a weight loss diet used in association with a lipase inhibitor.

Claim (Index 8):
The method of  claim 1  wherein the fat-soluble nutrient is selected from the group consisting of fat-soluble vitamins, carotenoids, and mixtures thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 2.07692
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15032895', '11866610', '15509766', '14009981', '14274133']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7873937566294956
- 35 USC 102 Novelty (BERT): 0.59312392585945
- Combined Prediction Score: 0.7679667735524911
- Mean Citation Score: 276.18713
- Max Citation Score: 556.23285
- Similarity Product: 423.12161411613823

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test